With $250m in SPAC Oaktree Acquisition Corp. II’s trust account, Alvotech has signed terms for additional capital facilities worth up to $250m in the face of looming shareholder redemptions.
Alvotech’s proposed merger with a blank cheque company has been shored up against the potential of higher-than-expected shareholder redemptions, after it signed terms for a financial backstop including both a standby equity agreement and a debt facility worth up to a combined $250m.
A standby equity purchase agreement facility from Ya Ii Pn, Ltd., a hedge fund operated by Yorkville Advisors Global, provides...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
